Release date: 2024-07-10 14:49:13 Recommended: 210

TABRECTA is suitable for treating adult patients with metastatic non-small cell lung cancer (NSCLC), whose tumors have mutations that lead to a jump in exon 14 of mesenchymal epithelial transition (MET) according to FDA approved testing. MET gene mutation is one of the rare mutations in lung cancer, including MET14 jump mutation (3%) and MET amplification (1%).
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of L···【more】
Recommended:399Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appoint···【more】
Recommended:396Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensi···【more】
Recommended:458Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in t···【more】
Recommended:324Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has ···【more】
Recommended:532Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea···【more】
Recommended:324Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended:505Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended:398Release date: 2024-07-09
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the r···【more】
Recommended:158Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved nirap···【more】
Recommended:153Release date: 2025-12-15
The U.S. Food and Drug Administration (FDA) announced today that it has approved···【more】
Recommended:171Release date: 2025-12-10
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisoca···【more】
Recommended:153Release date: 2025-12-08
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full ap···【more】
Recommended:187Release date: 2025-12-04
Primary analysis data from the randomized, double-blind, placebo-controlled phas···【more】
Recommended:166Release date: 2025-12-01